Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.

Zhang B, Liu S, Zhang Z, Wei J, Qu Y, Wu K, Yang Q, Hou P, Shi B.

Diagn Pathol. 2014 Mar 3;9:45. doi: 10.1186/1746-1596-9-45.

2.

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.

Clin Endocrinol (Oxf). 2006 Nov;65(5):660-6.

PMID:
17054470
3.

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.

PMID:
22500044
4.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.

PMID:
26152656
5.

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.

Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS.

Diagn Mol Pathol. 2008 Jun;17(2):118-25. doi: 10.1097/PDM.0b013e31815d059d.

PMID:
18382358
6.

[Clinical role of BRAF V600E mutation testing in thyroid nodules].

Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jun;49(6):468-72. Chinese.

PMID:
25241863
7.

Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.

Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.

Acta Cytol. 2011;55(6):576-83. doi: 10.1159/000333453. Epub 2011 Dec 9.

PMID:
22156469
8.

Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.

Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A.

World J Surg. 2010 Nov;34(11):2595-603. doi: 10.1007/s00268-010-0729-4.

PMID:
20652698
9.

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.

Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19.

PMID:
22181337
10.

Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.

Lee KH, Kim HS, Han BK, Ko EY, Ki CS, Shin JH.

AJR Am J Roentgenol. 2014 Feb;202(2):391-6. doi: 10.2214/AJR.12.10291.

PMID:
24450682
11.
12.

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.

Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M.

Clin Endocrinol (Oxf). 2007 May;66(5):678-83. Epub 2007 Mar 23.

PMID:
17381488
13.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.

Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021. Epub 2011 May 13.

PMID:
21568726
14.

BRAF(V600E) mutation analysis from May-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma.

Patel A, Klubo-Gwiezdzinska J, Hoperia V, Larin A, Jensen K, Bauer A, Vasko V.

Endocr Pathol. 2011 Dec;22(4):195-9. doi: 10.1007/s12022-011-9180-9.

PMID:
21948220
15.

BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.

Chang H, Lee H, Yoon SO, Kim H, Kim A, Kim BH.

Hum Pathol. 2012 Jan;43(1):89-95. doi: 10.1016/j.humpath.2011.04.010. Epub 2011 Jul 19.

PMID:
21774961
16.

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC.

Eur J Endocrinol. 2009 Sep;161(3):467-73. doi: 10.1530/EJE-09-0353. Epub 2009 Jul 2.

17.

Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.

Yeo MK, Liang ZL, Oh T, Moon Y, An S, Kim MK, Kim KS, Shong M, Kim JM, Jo YS.

Clin Endocrinol (Oxf). 2011 Oct;75(4):555-60. doi: 10.1111/j.1365-2265.2011.04115.x.

PMID:
21609347
18.

Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.

Park KS, Oh YL, Ki CS, Kim JW.

J Mol Diagn. 2015 Jul;17(4):431-7. doi: 10.1016/j.jmoldx.2015.03.006. Epub 2015 Apr 30.

PMID:
25937618
19.

Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.

Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.

J Clin Endocrinol Metab. 2011 Mar;96(3):658-64. doi: 10.1210/jc.2010-1082. Epub 2011 Jan 14.

PMID:
21239517
20.

Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.

Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.

Cancer Cytopathol. 2015 Oct;123(10):593-602. doi: 10.1002/cncy.21586. Epub 2015 Jul 31.

Supplemental Content

Support Center